Cargando…

Impact of Pre-Existing Immunity to Influenza on Live-Attenuated Influenza Vaccine (LAIV) Immunogenicity

During the previous influenza seasons, between 2010 and 2016, the live attenuated influenza vaccine (LAIV) provided variable efficacy against influenza in the U.S., causing the recommendation against the use of the LAIV. In striking contrast, pre-clinical studies have repeatedly demonstrated superio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roy, Sreeja, Williams, Clare M., Wijesundara, Danushka K., Furuya, Yoichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711626/ https://www.ncbi.nlm.nih.gov/pubmed/33207559 http://dx.doi.org/10.3390/vaccines8040683

Ejemplares similares

Impact of Pre-Existing Immunity on Live Attenuated Influenza Vaccine-Induced Cross-Protective Immunity
por: Roy, Sreeja, et al.
Publicado: (2020)

Fear of Influenza Resurgence amid COVID-19 Pandemic: Need for Effective Flu Vaccine Still Exists
por: Wijesundara, Danushka K., et al.
Publicado: (2021)

Detrimental impact of allergic airway disease on live attenuated influenza vaccine
por: Roy, Sreeja, et al.
Publicado: (2021)

LUNG group 2 innate lymphoid cells as a new adjuvant target to enhance intranasal vaccine efficacy against influenza
por: Williams, Clare M, et al.
Publicado: (2022)

Safety of live attenuated influenza vaccine (LAIV) in children with moderate to severe asthma
por: Turner, Paul J., et al.
Publicado: (2020)

Evaluation of the Safety and Immunogenicity of a Candidate Pandemic Live Attenuated Influenza Vaccine (pLAIV) Against Influenza A(H7N9)
por: Sobhanie, Mahdee, et al.
Publicado: (2016)

The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study
por: Rose, Markus A, et al.
Publicado: (2014)

Differences in nasal immunoglobulin A responses to influenza vaccine strains after live attenuated influenza vaccine (LAIV) immunization in children
por: Turner, P. J., et al.
Publicado: (2019)

Update: ACIP Recommendations for the Use of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) — United States, 2018–19 Influenza Season
por: Grohskopf, Lisa A., et al.
Publicado: (2018)

Epidemiological Impact of the Pediatric Live Attenuated Influenza Vaccine (LAIV) Program on Group A Streptococcus (GAS) Infection in England
por: Sinnathamby, Mary A, et al.
Publicado: (2023)

Cost-effectiveness analysis of intranasal live attenuated vaccine (LAIV) versus injectable inactivated influenza vaccine (TIV) for Canadian children and adolescents
por: Tarride, Jean-Eric, et al.
Publicado: (2012)

1663. Marked Improvement in Pandemic H1N1 Component Shedding and Immunogenicity in 2017–2018 Russian-Backbone Live Attenuated Influenza Vaccine (LAIV) in Gambian Children
por: Lindsey, Benjamin, et al.
Publicado: (2018)

An intercountry comparison of the impact of the paediatric live attenuated influenza vaccine (LAIV) programme across the UK and the Republic of Ireland (ROI), 2010 to 2017
por: Sinnathamby, Mary A., et al.
Publicado: (2023)

Comparative Immunogenicity of the 2014–2015 Northern Hemisphere Trivalent IIV and LAIV against Influenza A Viruses in Children
por: Ang, Jann Catherine, et al.
Publicado: (2019)

664 Influenza Vaccination in Chronically Ill Children: Taking a Closer Look at LAIV
por: Merckx, Joanna, et al.
Publicado: (2014)

1060 The Effect of Live Attenuated Influenza Vaccine (LAIV) on Bacterial Colonization in Healthy 2-4 Year Old Children. A Randomised Controlled Study
por: Thors, Valtyr, et al.
Publicado: (2014)

Safety and Viral Shedding of Live Attenuated Influenza Vaccine (LAIV) in Chinese Healthy Juveniles and Adults: A Phase Ⅰ Randomized, Double-Blind, Placebo-Controlled Study
por: Li, Li, et al.
Publicado: (2022)

Successes and Failures of the Live-attenuated Influenza Vaccine: Can We Do Better?
por: Matrajt, Laura, et al.
Publicado: (2020)

Viral Shedding in Recipients of Live Attenuated Influenza Vaccine in the 2016–2017 and 2017–2018 Influenza Seasons in the United Kingdom
por: Jackson, David, et al.
Publicado: (2020)

Development and Pre-Clinical Evaluation of Two LAIV Strains against Potentially Pandemic H2N2 Influenza Virus
por: Isakova-Sivak, Irina, et al.
Publicado: (2014)

2015–2016 Vaccine Effectiveness of Live Attenuated and Inactivated Influenza Vaccines in Children in the United States
por: Poehling, Katherine A, et al.
Publicado: (2018)

Evaluation of the safety of live attenuated influenza vaccine (LAIV) in children and adolescents with asthma and high-risk conditions: a population-based prospective cohort study conducted in England with the Clinical Practice Research Datalink
por: Caspard, Herve, et al.
Publicado: (2018)

Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines
por: Sridhar, Saranya, et al.
Publicado: (2015)

Bordetella bronchiseptica Colonization Limits Efficacy, but Not Immunogenicity, of Live-Attenuated Influenza Virus Vaccine and Enhances Pathogenesis After Influenza Challenge
por: Hughes, Holly R., et al.
Publicado: (2018)

Correction: Evaluation of the safety of live attenuated influenza vaccine (LAIV) in children and adolescents with asthma and high-risk conditions: a population-based prospective cohort study conducted in England with the Clinical Practice Research Datalink
Publicado: (2019)

The impact of pre‐existing influenza antibodies and inflammatory status on the influenza vaccine responses in older adults
por: Kang, Min, et al.
Publicado: (2023)

Immunogenicity and Protective Efficacy of Seasonal Human Live Attenuated Cold-Adapted Influenza Virus Vaccine in Pigs
por: Holzer, Barbara, et al.
Publicado: (2019)

Intranasal powder live attenuated influenza vaccine is thermostable, immunogenic, and protective against homologous challenge in ferrets
por: Luczo, Jasmina M., et al.
Publicado: (2021)

The Effects of Pre-Existing Antibodies on Live-Attenuated Viral Vaccines
por: Mok, Darren Z. L., et al.
Publicado: (2020)

Adjuvant Selection for Influenza and RSV Prefusion Subunit Vaccines
por: Isaacs, Ariel, et al.
Publicado: (2021)

Use and Misuse of Statistical Significance in Survival Analyses
por: Furuya, Yoichi, et al.
Publicado: (2014)

The influenza vaccines roadmap – A better future through improved influenza vaccines
por: Hart, Peter, et al.
Publicado: (2021)

Effects of Prior Influenza Exposure on Immunogenicity of Influenza Vaccine
por: Cao, Jia-Qian, et al.
Publicado: (2020)

Acceptability of intranasal live attenuated influenza vaccine, influenza knowledge and vaccine intent in The Gambia
por: Armitage, Edwin P., et al.
Publicado: (2018)

Immunogenicity and Viral Shedding of Russian-Backbone, Seasonal, Trivalent, Live, Attenuated Influenza Vaccine in a Phase II, Randomized, Placebo-Controlled Trial Among Preschool-Aged Children in Urban Bangladesh
por: Lewis, Kristen D C, et al.
Publicado: (2019)

Cytolytic Perforin as an Adjuvant to Enhance the Immunogenicity of DNA Vaccines
por: Shrestha, Ashish C., et al.
Publicado: (2019)

Respiratory PCR detects influenza after intranasal live-attenuated influenza vaccination
por: Lumley, S, et al.
Publicado: (2013)

Correlates of Immunity to Influenza as Determined by Challenge of Children with Live, Attenuated Influenza Vaccine
por: Wright, Peter F., et al.
Publicado: (2016)

Live Attenuated Influenza H7N3 Vaccine is Safe, Immunogenic and Confers Protection in Animal Models
por: Rekstin, Andrey, et al.
Publicado: (2014)

Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I–II clinical trials)
por: Rudenko, Larisa, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_h9srvoi46vbb9ije7p7vinuctc